Announced Thu, 25 Jun · 12:34 IST
Fabtech board approves Rs 26.49 Cr investment in two subsidiaries, director exit
Strategic Transactions View source PDF
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹156.89
prior close
₹158.83
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.5+0.4+0.5-0.3+0.1+2.8+5.4+3.6-2.1-5.5——
Up moveDown movePending
AI summary
Board approved up to Rs 24 Cr investment in UAE-based wholly-owned subsidiary Fabtech Technologies LLC via overseas direct investment. Also approved Rs 2.49 Cr infusion in pharma subsidiary FT Institutions Private Limited. Independent Director Shyam Khante completed his tenure and ceased to be a director. Borrowing limit raised within statutory cap, so no shareholder approval needed. Audit, NRC, and CSR committees reconstituted effective June 26.
Likely market impact
Capital infusion into existing subsidiaries signals overseas and pharma expansion push. Director exit and committee changes are routine with no material impact.